Fenofibrate improves endothelial function in the brachial artery and forearm resistance arterioles of statin-treated Type 2 diabetic patients.
about
Aging and vascular endothelial function in humansEndothelial dysfunction in diabetes: pathogenesis, significance, and treatment.Fenofibrate: a review of its lipid-modifying effects in dyslipidemia and its vascular effects in type 2 diabetes mellitus.Management of dyslipidemias with fibrates, alone and in combination with statins: role of delayed-release fenofibric acid.A review of time courses and predictors of lipid changes with fenofibric acid-statin combination.Extended-Release Niacin Versus Fenofibrate in HIV-Infected Participants With Low High-Density Lipoprotein Cholesterol: Effects on Endothelial Function, Lipoproteins, and Inflammation.Endothelial function in mild primary hyperparathyroidism.Fenofibrate improves vascular endothelial function by reducing oxidative stress while increasing endothelial nitric oxide synthase in healthy normolipidemic older adultsDiabetic retinopathy and endothelial dysfunction in patients with type 2 diabetes mellitus.Current role of fenofibrate in the prevention and management of non-alcoholic fatty liver diseaseMaking sense in antisense: therapeutic potential of noncoding RNAs in diabetes-induced vascular dysfunction.Fenofibrate improves endothelial function and plasma myeloperoxidase in patients with type 2 diabetes mellitus: an open-label interventional study.AS04-adjuvanted human papillomavirus (HPV) types 16 and 18 vaccine (Cervarix®): a review of its use in the prevention of premalignant cervical lesions and cervical cancer causally related to certain oncogenic HPV types.Fenofibrate plus simvastatin (fixed-dose combination) for the treatment of dyslipidaemia.Exercise attenuates the premature cardiovascular aging effects of type 2 diabetes mellitus.Cardiometabolic impact of non-statin lipid lowering therapies.
P2860
Q28390251-5784839D-E888-4183-9220-0BCC17FAB3A5Q33776230-42546E4C-9765-47C5-90DB-D01C81D7E405Q33933474-24988D00-5C3C-4996-8695-FB584BACE9B0Q34068746-D4EBECA3-A076-44CD-A49F-CCE26AE9789EQ36011053-075200AD-F753-4A10-8E7C-693C620D52A0Q36087108-02D748A5-893A-49BA-83CE-BB6F5087951EQ36342107-1C356270-843A-45CD-B3FB-0F11C76EF64DQ36933753-B1DB354C-8961-49FF-BC8C-D17DE4DEDD43Q37121601-4362637F-EF5B-4087-9B64-6C21751183C6Q37196514-FAE4D472-04AA-412A-905E-04DEB00C60AEQ37393027-09B1F6AA-C2A6-4027-A92A-21949CBDBE1DQ37681585-51B77389-7E80-4304-9DAD-A891F9A38F19Q37851958-4D806334-7235-4808-9BEF-D1638F468251Q37898699-9F4A144D-CD97-4340-8EBD-E5BEB0B6EEFCQ37926770-5E7C8FB2-018C-498B-953D-0B7D78DD1FEEQ38176275-1DFAA2E4-3572-415C-A5AF-35A99C338A95
P2860
Fenofibrate improves endothelial function in the brachial artery and forearm resistance arterioles of statin-treated Type 2 diabetic patients.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Fenofibrate improves endotheli ...... ated Type 2 diabetic patients.
@en
Fenofibrate improves endotheli ...... ated Type 2 diabetic patients.
@nl
type
label
Fenofibrate improves endotheli ...... ated Type 2 diabetic patients.
@en
Fenofibrate improves endotheli ...... ated Type 2 diabetic patients.
@nl
prefLabel
Fenofibrate improves endotheli ...... ated Type 2 diabetic patients.
@en
Fenofibrate improves endotheli ...... ated Type 2 diabetic patients.
@nl
P2093
P2860
P356
P1433
P1476
Fenofibrate improves endotheli ...... ated Type 2 diabetic patients.
@en
P2093
Gerald F Watts
Gerard T Chew
Sandra J Hamilton
Timothy M E Davis
P2860
P304
P356
10.1042/CS20090568
P407
P577
2010-02-23T00:00:00Z